09:30
The biomedical industry steps into the era of personalized healthcare
08:59
Amplefields Investments: “2024 was a year of strategic recalibration and strength”
08:59
Unlocking the IPO floodgates: Is 2025 the year public markets revive?
08:30
Revealense appoints Dr. Yacov Bengo as Head of Defense
